Back to funds
View filing
Opaleye Management Inc.
Updated 6 days agoManaged by Opaleye Management Inc. • Latest filing Q3 2026
Portfolio value
$887.7M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $758M |
| Q1 2026 | $759.2M |
| Q2 2026 | $1.1B |
| Q3 2026 | $887.7M |
Top holdings
58 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $125.6M | 2.44M | 14.15% | — | |
| 2 | $71.7M | 1.09M | 8.07% | — | |
| 3 | $64.8M | 2.10M | 7.30% | — | |
| 4 | $63.8M | 2.11M | 7.19% | — | |
| 5 | $58.5M | 1.44M | 6.59% | — | |
| 6 | $41.2M | 555.0K | 4.64% | — | |
| 7 | $39.6M | 3.60M | 4.46% | — | |
| 8 | $31.1M | 557.0K | 3.50% | — | |
| 9 | $29.7M | 3.30M | 3.35% | — | |
| 10 | ? N/A IMMIX BIOPHARMA INC | $29.4M | 2.83M | 3.31% | — |
| 11 | $24M | 1.65M | 2.71% | — | |
| 12 | $22.2M | 2.75M | 2.50% | — | |
| 13 | $20.5M | 100.0K | 2.31% | — | |
| 14 | $18.3M | 1.38M | 2.07% | — | |
| 15 | $18M | 692.2K | 2.03% | — | |
| 16 | $17.8M | 1.05M | 2.00% | — | |
| 17 | $16.9M | 4.09M | 1.91% | — | |
| 18 | $15.9M | 1.19M | 1.79% | — | |
| 19 | $14.1M | 100.0K | 1.59% | — | |
| 20 | $12.3M | 1.03M | 1.39% | — |